235 related articles for article (PubMed ID: 23111336)
1. Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia.
Liu X; An C; Jin P; Liu X; Wang L
Biomaterials; 2013 Jan; 34(3):817-30. PubMed ID: 23111336
[TBL] [Abstract][Full Text] [Related]
2. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.
Liu X; Ye M; An C; Pan L; Ji L
Biomaterials; 2013 Sep; 34(28):6893-905. PubMed ID: 23768781
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
4. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
Lu W; Wan J; She Z; Jiang X
J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
[TBL] [Abstract][Full Text] [Related]
5. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles.
Xu F; Lu W; Wu H; Fan L; Gao X; Jiang X
J Drug Target; 2009 Jul; 17(6):423-34. PubMed ID: 19527113
[TBL] [Abstract][Full Text] [Related]
6. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
Xie YL; Lu W; Jiang XG
Behav Brain Res; 2006 Oct; 173(1):76-84. PubMed ID: 16828890
[TBL] [Abstract][Full Text] [Related]
8. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
[TBL] [Abstract][Full Text] [Related]
9. Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund's adjuvant (CFA)-induced inflammatory pain.
Sun S; Yin Y; Yin X; Cao F; Luo D; Zhang T; Li Y; Ni L
Brain Res Bull; 2012 Sep; 88(6):581-8. PubMed ID: 22705002
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA attenuates neuropathic pain via inhibiting glial activation and immune response.
Cao FL; Xu M; Wang Y; Gong KR; Zhang JT
Pharmacol Biochem Behav; 2015 Jan; 128():1-7. PubMed ID: 25449357
[TBL] [Abstract][Full Text] [Related]
12. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
Zhang WL; Liu JP; Liu XX; Chen ZQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
[TBL] [Abstract][Full Text] [Related]
13. Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes.
Pang Z; Gao H; Chen J; Shen S; Zhang B; Ren J; Guo L; Qian Y; Jiang X; Mei H
Int J Nanomedicine; 2012; 7():3421-32. PubMed ID: 22848168
[TBL] [Abstract][Full Text] [Related]
14. [Effect of tanshinone IIA pretreatment on IL-1β and RelA mRNA expression in rats with focal cerebral ischemia].
Chen WY; Sun CM; Wang HM; Huang M; Zhu GX; Zhu BD; Liu FY
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2115-8. PubMed ID: 20855265
[TBL] [Abstract][Full Text] [Related]
15. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
16. PEG-
Xu G; Gu H; Hu B; Tong F; Liu D; Yu X; Zheng Y; Gu J
Int J Nanomedicine; 2017; 12():2243-2254. PubMed ID: 28356740
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
18. Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting.
Agarwal A; Agrawal H; Tiwari S; Jain S; Agrawal GP
Int J Pharm; 2011 Dec; 421(1):189-201. PubMed ID: 21986113
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal-regulated protein kinase pathways in rats challenged with seawater exposure.
Li JH; Xu M; Xie XY; Fan QX; Mu DG; Zhang Y; Cao FL; Wang YX; Zhao PT; Zhang B; Jin FG; Li ZC
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):269-77. PubMed ID: 21314841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
